A photo with the logo of the Swiss pharmaceutical giant Roche in Basel.
SEBASTIEN BOZON | AFP | Getty Images
Drug maker Roche said Friday it has received emergency use approval from the U.S. Food and Drug Administration for a test that can quickly determine whether a patient has SARS-CoV-2 or one of two forms of influenza Has
"With the flu season approaching, this new test is particularly important as SARS-CoV-2 and influenza infections can hardly be distinguished by symptoms alone. With a single test, healthcare professionals can now confidently make the correct diagnosis and the most effective treatment plan for their patients Patients, "said Thomas Schinecker, head of Roche diagnostics, in a statement.